A Story of Innovation
Thanks to continued commitment to innovation ever since its creation, Medtech is a major player in the French market for surgical robotics today.
Following the sale of Medtech’s initial orthopedic surgical robot BRIGIT®'s patent portfolio, Medtech created ROSA® Brain, its first neurosurgical robot. ROSA® quickly received CE marking and FDA approval, allowing it to be sold for clinical use both in Europe and the United States.
Since 2012, encouraged by the success of ROSA® Brain, Medtech has continued to innovate with a new R&D project pertaining to spinal surgery. In cooperation with the Languedoc-Roussillon regional council and OSEO, Medtech is striving to meet and exceed the needs of neurosurgeons in this complex area of robotic technology.
ROSA® Spine, the new robotic assistant for spine surgery, obtained CE marking in July 2014 and is currently being adopted throughout Europe. Following the CE marking, the first intervention with ROSA® Spine was performed in November 2014 and its 100th spine operation in May 2016. The ROSA® Spine device received FDA clearance in January 2016.